About
blueprint medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. our approach is rooted in a deep understanding of the genetic blueprint of c
CEOJeffrey Albers
HQCambridge, Massachusetts
Employees686